U.S.-China Drugs Tie-ups Come Under Threat
A surge in dealmaking that's helped Chinese biotech and healthcare firms sell their products globally faces several headwinds.
Articles
Beijing’s Uranium Edge
China has the upper hand in the battle for nuclear fuel but is on the hunt for more.
A Seat at Xi’s Table
A deep dive into the private companies invited to meet the Chinese leader.
The Quantum Panic
The U.S. wants to be prepared for whatever quantum technologies bring, but is it time to rightsize the threat from China?
Mark Clifford on Why Jimmy Lai’s Story Matters
The former journalist talks about writing the biography of Apple Daily’s publisher, his ongoing national security trial in Hong Kong, and hopes for a political solution.
TikTok Refugees Head for Other Chinese Apps as Ban Looms
Chinese social media app Xiaohongshu has seen a surge in American users in recent days, but the trend could prove temporary.
Developing Countries Want More Than Just Cash From China
Emerging markets are still welcoming towards Chinese capital — but increasingly on their own terms.
The Great Brew Battle
After its Nasdaq-shaking accounting scandal of 2020, Luckin Coffee has staged a legendary comeback, surpassing even Starbucks in China in terms of revenue and store count. But the bad blood between Luckin's current and ousted leadership has resulted in a near clone, Cotti Coffee, as...
Chinese Robots Hit the Factory Floor
Chinese industrial robot makers have succeeded in taking a bigger share of the domestic market. Can they compete globally?
Hong Kong’s Democracy Movement Receives Its Sentence
The city’s largest ever national security trial has ended with years-long jail terms handed to dozens of activists. A Wire China timeline shows how Hong Kong reached this point.
The Tipping Point
Foreign companies face a reckoning in China as the risks of staying are generating diminishing returns.
Big Pharma Doubles Down on China
Foreign pharmaceutical firms are eyeing the world’s second largest market for profit opportunities as well as innovative assets.